The following are companies that we currently invest in.
Click on a logo to visit the website.

		Ardana plc Drugs for womens health and reproductive disorders
		Ark Therapeutics Group plc Gene-based drugs for vascular and circulatory diseases and cancer
		Biovex Group Inc Viral vectors to deliver therapeutic vaccines
		Biowisdom Ltd Knowledge management software for drug development
		Cyclacel Pharmaceutical Inc. Cell cycle control drugs for cancer
		De Novo Pharmaceuticals Ltd In silico structure-based drug design
		Decon Sciences Ltd Decontamination services provider
		Emergent BioSolutions Inc Research, development and manufacture of novel vaccines and related products
		Energist Ltd Variable pulsed light therapy
		EpiCept Inc Topical pain management
		Intercytex Group plc Hair and tissue regrowth
		Lab 21 Ltd Clinical and environmental monitoring
		LiDCO Group plc Cardiac output monitors
		Neurotech Inc Cell-based drugs for diseases of the eye
		Noxxon Pharma AG Mirror image oligonucleotide drugs
		Onyvax Ltd Whole-cell allogenic vaccines for cancer
		PanTherix Ltd Novel broad-spectrum antibiotics
		PIramed Ltd Oncology Therapeutics
		Plethora Solutions Holdings plc Discovering and developing urological products
		ReNeuron Group plc Treatments for neurological disorders
		Santhera Pharmaceuticals AG Small molecule therapeutics for neuromuscular and metabolic diseases
		Sosei Co. Ltd Identifying new uses for established drugs
		Vectura Group plc Drug formulations and devices for respiratory diseases
		Virgin Health Bank Ltd Cord blood banking
		VivoMedica plc Advancing medical devices from prototype to market
		White Light Therapy Ltd Skin treatment and hair removal
		Wilex AG Antibody and small molecule cancer therapies
		York Pharma plc Acquisition, development and commercialisation of prescription dermatological products